filmov
tv
Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours

Показать описание
Presented By: Jane Bayani
Speaker Biography: Dr. Bayani is a Principal Research Scientist at the Ontario Institute for Cancer Research in the Department of Diagnostic Development. She obtained her PhD at the University of Toronto in the Department of Laboratory Medicine and Pathobiology. She has an extensive background in molecular pathology and molecular cytogenetics and now leads a number of the genomic translational research projects as part of the senior scientific team in Diagnostic Development.
Webinar: Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
Webinar Abstract: Precision oncology continues to evolve as additional clinically relevant biomarkers are identified. The challenges facing the clinical researchers include not only the ability to add additional relevant biomarkers to existing tests, but ensuring they are adequately validated and robust for translation into a clinical research setting. The Oncomine Comprehensive Assay v3 has been implemented for use in both translational and clinical research projects including the NCI MATCH trial and shown reproducible and robust results.
Speaker Biography: Dr. Bayani is a Principal Research Scientist at the Ontario Institute for Cancer Research in the Department of Diagnostic Development. She obtained her PhD at the University of Toronto in the Department of Laboratory Medicine and Pathobiology. She has an extensive background in molecular pathology and molecular cytogenetics and now leads a number of the genomic translational research projects as part of the senior scientific team in Diagnostic Development.
Webinar: Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
Webinar Abstract: Precision oncology continues to evolve as additional clinically relevant biomarkers are identified. The challenges facing the clinical researchers include not only the ability to add additional relevant biomarkers to existing tests, but ensuring they are adequately validated and robust for translation into a clinical research setting. The Oncomine Comprehensive Assay v3 has been implemented for use in both translational and clinical research projects including the NCI MATCH trial and shown reproducible and robust results.
Evaluation of the Oncomine™ Comprehensive Assay v3 and early experience with the Oncomine...
Evaluation of the Oncomine Comprehensive Assay Plus for Profiling of Solid Tumours
Comprehensive assessment of myeloid malignancies with Oncomine Myeloid Research Assay
Genomic instability metric GIM for HRD assessment | Oncomine Comprehensive Assay Plus...
Oncomine the best solution for precision medicine
How Does Oncomine Research Informatics Enhance NGS Post-sequencing Analysis? Seq It Out #21
AACR 2015 Poster: The Oncomine Comprehensive Assay
Evaluation of Genexus Integrated Sequencer that Automates Specimen-to-report for Cancer Genomic...
Seth Sadis - Intelligent NGS Assay Design Oncomine™ Focus Assay for NGS clinical research in oncol...
What do 'Oncomine Solutions' mean to you?
How Does Oncomine Research Informatics Enhance NGS Post-sequencing Analysis? Seq It Out #21
Evaluation of a Pan-Cancer Cell-Free Assay to Meet Unmet Research Needs
Oncomine® applications for cancer research
Advantages and Challenges of Broad Molecular Profiling
The One-Day NGS: the revolution in pathology labs is now
Oncomine Reporter - Integrated Reporting for Solid Tumor and Myeloid Somatic Variants
Oncomine® NGS Power Tools
Deliver comprehensive genomic profiling results w/ Oncomine Solutions for Ion Torrent Genexus System
Oncomine Dx Target test for precision oncology NGS testing in NSCLC
Oncomine Tumor Mutation Load Assay compared to FoundationOne test
The Oncomine Focus Assay: Multi-Biomarker NGS Panel | AACR 2015
Using the Oncomine Tumor Mutation Load Assay
Oncomine - Advanced Analysis
Simultaneous DNA and RNA variant testing by Oncomine™ Precision Assay
Комментарии